$ALNY News Article - Alnylam Submits Regulatory Applications to the U.S. Food and Drug Administration and European Medicines Agency to Support Label Expansion for OXLUMO for the Treatment of Advanced Primary Hyperoxaluria Type 1
https://marketwirenews.com/news-releases/alny...54549.html